Ergothioneine
Evidence Summary
An amino acid derivative notable for having a dedicated transporter in human tissue, which is unusual and has driven scientific interest. Human trials are few and use biomarker endpoints. The pivotal randomised trial was funded by a single manufacturer, so the reported effect should be treated as an upper bound rather than a point estimate.
Evidence Signals (0)
Products Containing Ergothioneine
No commercial products are currently listed for this molecule.
This evidence profile reflects publicly available research as of October 22, 2026. Evidence grades may change as new research is published. ClinEvident grades the quality of published evidence — it does not evaluate the efficacy of any specific commercial product.